Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2+ gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 Meeting Abstract
| Authors: | Janjigian, Y. Y.; Oh, D. Y.; Rha, S. Y.; Lee, K. W.; Steeghs, N.; Chao, Y.; Di Bartolomeo, M.; Garcia, M. D.; Mohammad, N. H.; Stein, A.; McAdoo, W.; Winter, M.; Croydon, L.; Lee, J. |
| Abstract Title: | Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2+ gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 |
| Meeting Title: | 2022 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2022 Jan 20-22 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-01 |
| Language: | English |
| ACCESSION: | WOS:000770995900287 |
| DOI: | 10.1200/JCO.2022.40.4_suppl.295 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 295 -- Meeting was conducted online as well as in person -- Source: Wos |
